Chloe E. Barr
St Mary's Hospital
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population.
Journal: Cancer research communications
Published: March 10, 2025
Measuring HE4 alongside CA125 for ovarian cancer diagnosis: A pilot clinical study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: September 21, 2023
Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women.
Journal: Cancers
Published: January 09, 2023
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features.
Journal: Diagnostics (Basel, Switzerland)
Published: October 13, 2022
Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: August 10, 2022
Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer.
Journal: Cancers
Published: May 26, 2022
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population.
Journal: Cancers
Published: March 17, 2022
Current and Emerging Prognostic Biomarkers in Endometrial Cancer.
Journal: Frontiers in oncology
Published: March 07, 2022
Urinary biomarkers for the detection of ovarian cancer: a systematic review.
Journal: Carcinogenesis
Published: September 13, 2021
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis.
Journal: PloS one
Published: September 09, 2021
Last Updated: 09/26/2026